During Dr. McCullough's 2021 interview with Joe Rogan, I was asked a challenging question: “Dr. McCullough, if the COVID-19 vaccines are harmful, why isn't everyone dying after receiving them?”
Although it may sound naive and ridiculous, it is actually a valid question that highlights the purpose of epidemiology, which is to analyze the patterns and causes of diseases.
A study conducted by Zogby in 2022 found that around 15% of people who receive a COVID-19 vaccine experience a health problem. This can be influenced by factors such as the lot number of the vaccine (which can indicate the amount of mRNA or contaminants present), the individual's susceptibility to adverse reactions, and any pre-existing conditions they may have (such as an inherited blood clotting disorder).
Hospitalization of young people after receiving a COVID-19 vaccine should not occur as the risk of such an outcome outweighs any potential benefits of the vaccine.
Yonker et al conducted a study at Massachusetts General Hospital and Harvard School of Medicine involving 16 young people hospitalized with myocarditis, 13 of whom were boys and 3 were girls. The study found that all of the participants had high levels of free circulating Spike protein generated from the vaccines. In contrast, control subjects who did not have myocarditis did not have these high levels of Spike protein.
It is possible that certain individuals do not produce the necessary neutralizing antibodies after being injected with the Spike protein, allowing it to circulate and negatively impact the body, particularly the heart muscle. This is despite the fact that there was a supposedly adequate library of antibodies in place to neutralize it.
Currently, there is a race to create Spike protein tests and monoclonal antibodies that could neutralize the Spike protein induced by COVID-19 vaccines and prevent heart damage. Interestingly, the government previously removed monoclonal antibodies from the market, as they were predicted to be ineffective against new strains. However, these products could now be effective against the old Spike protein generated by the COVID-19 vaccines. More research is necessary to determine their effectiveness.
More research should be conducted on the pathophysiology of COVID-19 vaccine-induced myocarditis after reading this paper, which is considered “positive,” to help the thousands of young people who are currently experiencing heart damage as a result of the vaccine.
